KESTRA MEDICAL TECHNOLOGIES, LTD.
KMTSUnited States
14 filed reports · 255 financial concepts · 1 earnings calls · 0 media appearances
Filed reports
14 reports · Jan 2025 to Jul 2026Each report counts once it has at least one extracted financial fact. Also extracted from these reports: 16 guidance figures, 25 commentary passages.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Current · 8-KSEC EDGAR | 7 | 20 | Jan 2025 to Jul 2026 |
| Quarterly · 10-QSEC EDGAR | 5 | 850 | Jan 2025 to Jul 2026 |
| Annual · 10-KSEC EDGAR | 2 | 793 | Apr 2025 to Apr 2026 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2026 Q1 | 8-K | Jul 31, 2026 | Sep 14, 2026 | 4 | Open |
| FY2026 Q1 | 10-Q | Jul 31, 2026 | Sep 14, 2026 | 333 | Open |
| FY2026 | 10-K | Apr 30, 2026 | Jul 14, 2026 | 534 | Open |
| FY2026 Q4 | 8-K | Apr 30, 2026 | Jul 14, 2026 | 4 | Open |
| FY2026 Q3 | 10-Q | Jan 31, 2026 | Mar 17, 2026 | 203 | Open |
| FY2026 Q3 | 8-K | Jan 31, 2026 | Mar 17, 2026 | 2 | Open |
| FY2026 Q2 | 10-Q | Oct 31, 2025 | Dec 11, 2025 | 177 | Open |
| FY2026 Q2 | 8-K | Oct 31, 2025 | Dec 11, 2025 | 2 | Open |
| FY2026 Q1 | 10-Q | Jul 31, 2025 | Sep 12, 2025 | 129 | Open |
| FY2026 Q1 | 8-K | Jul 31, 2025 | Sep 11, 2025 | 4 | Open |
| FY2025 | 10-K | Apr 30, 2025 | Jul 17, 2025 | 259 | Open |
| FY2025 Q4 | 8-K | Apr 30, 2025 | Jul 15, 2025 | 2 | Open |
Financial data
255 concepts · 1,663 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial251 concepts · 1,640 facts · Apr 2024 to Jul 2026
- Disposable medical equipment supplies14 · Apr 2024 to Jul 2026
- Cash and cash equivalents at carrying value13 · Apr 2024 to Jul 2026
- Cash cash equivalents restricted cash and restricted cash equivalents13 · Apr 2024 to Jul 2026
- Restricted cash13 · Apr 2024 to Jul 2026
- Stockholders equity including portion attributable to noncontrolling interest13 · Apr 2024 to Jul 2026
- Adjustments to additional paid in capital sharebased compensation requisite service period recognition value12 · Apr 2024 to Jul 2026
- Allocated share based compensation expense12 · Apr 2024 to Jul 2026
- Amortization of financing costs and discounts12 · Apr 2024 to Jul 2026
- Cash cash equivalents restricted cash and restricted cash equivalents period increase decrease including exchange rate effect12 · Apr 2024 to Jul 2026
- Cost of goods and services sold (US GAAP)12 · Apr 2024 to Jul 2026
- Deposits for medical rental equipment12 · Apr 2024 to Jul 2026
- Depreciation12 · Apr 2024 to Jul 2026
- Depreciation depletion and amortization12 · Apr 2024 to Jul 2026
- Disposable medical equipment supplies12 · Apr 2024 to Jul 2026
- Fair value measurement with unobservable inputs reconciliation recurring basis asset transfers net12 · Apr 2024 to Jul 2026
- Gain loss on sale of property plant equipment12 · Apr 2024 to Jul 2026
- Gross profit (US GAAP)12 · Apr 2024 to Jul 2026
- Income tax expense benefit12 · Apr 2024 to Jul 2026
- Increase decrease in accounts payable12 · Apr 2024 to Jul 2026
- Increase decrease in accounts receivable12 · Apr 2024 to Jul 2026
- Increase decrease in accrued liabilities and other operating liabilities12 · Apr 2024 to Jul 2026
- Increase decrease in operating lease liability12 · Apr 2024 to Jul 2026
- Increase decrease in other noncurrent assets12 · Apr 2024 to Jul 2026
- Increase decrease in prepaid deferred expense and other assets12 · Apr 2024 to Jul 2026
Guidance2 concepts · 20 facts · Apr 2025 to Sep 2026
- Revenue Guidance14 · Apr 2025 to Sep 2026
- Revenue Growth Guidance6 · Sep 2025 to Sep 2026
Geography1 concepts · 2 facts · Apr 2025 to Apr 2026
- Effective income tax rate reconciliation foreign income tax rate differential2 · Apr 2025 to Apr 2026
Product1 concepts · 1 facts · Apr 2025
- Depreciation1 · Apr 2025
Segments
3 factsFigures broken down by business line, region, product or another axis the company reports on.
Statement geographical1 member · 2 facts
- IE2 · Apr 2025 to Apr 2026
Product or service1 member · 1 facts
- Costs Of Revenue1 · Apr 2025
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
- Earnings-release commentary6 claims from 1 reports · Jul 2026
- Management discussion (MD&A) commentary19 claims from 1 reports · Jul 2026
Earnings calls
1 calls · Sep 2026Transcripts with management claims and analyst questions, one per fiscal period.
- FY2027 Q1Sep 14, 2026
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.